3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myeloproliferative Disorders
4
Recurrence
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Neuroblastoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hematologic Neoplasms
2
Transplant-Related Hematologic Malignancy
1
Teratoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
olaparib
2
lutetium Lu 177 dotatate
2
gallium Ga 68 dotatate
2
Fluorodeoxyglucose F18
2
6-fluorodopamine
2
tipifarnib
1
fluorodopa F 18
1
fludarabine phosphate
1
belzutifan
1
Temozolomide
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Cyclophosphamide
1
Contrast Media
1
CTLA-4 Antigen
1
Biopsy
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pheochromocytoma
×
Granulocyte Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.